Table 2 Multivariate analysis of clinical data and serum microRNA and their association with fibrosis in patients with CHB and CHC.
OR | 95% CI | p value | ||
---|---|---|---|---|
CHB patients | Serum miR-122 | 0.19 | 0.03–1.17 | 0.07 |
Serum miR-222 (x100) | 1.12 | 1.01–1.24 | 0.03 | |
Platelets | 0.99 | 0.98–1.00 | 0.09 | |
ALP (/10) | 1.21 | 1.04–1.41 | 0.01 | |
CHC patients | Hepatic miR-122 | 0.80 | 0.67–0.95 | 0.01 |
Hepatic miR-224 (x100) | 1.56 | 1.05–2.31 | 0.03 | |
Platelets | 0.97 | 0.95–0.99 | 0.004 | |
ALT (/10) | 1.09 | 0.96–1.24 | 0.17 | |
Albumin | 1.41 | 0.94–2.11 | 0.10 |